CompletedPhase 1NCT00002705
Topotecan in Treating Children With Refractory Leukemia
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Wayne Lee Furman, MDSt. Jude Children's Research Hospital
- Intervention
- topotecan hydrochloride(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 1996
Study locations (30)
- University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- University of California San Diego Cancer Center, La Jolla, California, United States
- Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
- Shands Hospital and Clinics, University of Florida, Gainesville, Florida, United States
- Emory University Hospital - Atlanta, Atlanta, Georgia, United States
- Children's Memorial Hospital, Chicago, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Via Christi Regional Medical Center, Wichita, Kansas, United States
- MBCCOP - LSU Medical Center, New Orleans, Louisiana, United States
- Johns Hopkins Oncology Center, Baltimore, Maryland, United States
- Boston Floating Hospital Infants and Children, Boston, Massachusetts, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Children's Hospital of Michigan, Detroit, Michigan, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002705 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University